LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Simple Breath Test Aids Type 1 Diabetes Early Diagnosis

By LabMedica International staff writers
Posted on 08 Dec 2014
Print article
Image: The AirSense is a mass spectrometer based on the patented Ion-Molecule Reaction (IMR-MS) and can be used for a broad field of applications (Photo courtesy of V&F).
Image: The AirSense is a mass spectrometer based on the patented Ion-Molecule Reaction (IMR-MS) and can be used for a broad field of applications (Photo courtesy of V&F).
A chemical marker has been identified for type 1 diabetes in the breath of children who are unaware they have the condition until they develop diabetic ketoacidosis, a potentially life-threatening complication and a breath test could pave the way to allow early diagnosis.

The symptoms of the diabetes mellitus type 1, which include increased thirst and urination, fatigue and weight loss, can be mistaken for symptoms of other disorders and some cases where type 1 diabetes is misdiagnosed in children. A recent study found that between 2001 and 2009, incidence of type 1 diabetes among children aged less than 9 years rose by 21%.

Biochemists at the University of Oxford (UK) collected breath samples from 113 children and adolescents aged 7 to 18 years that had been diagnosed with type 1 diabetes. The team measured levels of acetone and another ketone called isoprene in the participants' breath and compared them with ketone and glucose levels in the blood, measurements of which were taken at the same time as breath samples were collected.

The patients blew through a tube and a bacterial filter into a specially constructed 100 mL syringe which had the aim of ensuring that the gases collected were end tidal. The sealed bags were analyzed by means of a soft-ionization mass spectrometer (V & F Airsense; Absam, Austria). Acetone, isoprene and carbon dioxide concentrations were measured, with the instrument standardized for its sensitivity to these compounds by using previously calibrated gas samples. Each patient provided blood for an HbA1c measurement and had capillary blood glucose and β hydroxybutyrate (BHB) levels measured using a FreeStyle Optium meter (Abbott, Maidenhead, UK).

The investigators found increased levels of acetone in the breath of the participants who also had increased levels of a ketone called β hydroxybutyrate in their blood. The team found a weak association between increased breath acetone and increased blood glucose but concluded that single breath measurements of acetone do not provide a good measure of blood glucose levels in this cohort. The team has already produced a prototype of a small hand-held device to measure ketone levels in the breath, which is currently being tested in clinical trials.

Gus Hancock, PhD, a professor of chemistry and a senior author of the study said, “Our results have shown that it is realistically possible to use measurements of breath acetone to estimate blood ketones. If the relationship between breath acetone and blood ketone levels is true at higher levels of ketones, a simple breath test could assist with the management of sick days in children with diabetes, preventing hospital admissions by providing a warning of the possible development of diabetic ketoacidosis (DKA).” The study was published on November 25, 2014, in the Journal of Breath Research.

Related Links:

University of Oxford
V & F Airsense
Abbott 


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.